Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Dirk K.M. De Ruysscher"'
Autor:
Elaine A.C. Albers, MSc, Haiyan Zeng, MSc, Dirk K.M. De Ruysscher, PhD, Marianne A. Kuenen, PhD, Rob Kessels, PhD, Lizza E.L. Hendriks, PhD, Jose S.A. Belderbos, PhD, Sanne B. Schagen, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 5, Pp 100506- (2023)
Introduction: In the randomized controlled trial in patients with SCLC comparing standard prophylactic cranial irradiation (PCI) with hippocampal avoidance PCI (HA-PCI), we did not observe beneficial effects of HA-PCI on tested cognition. Here, we re
Externí odkaz:
https://doaj.org/article/c850dd7e4f0043138a6cb6a5711a9e10
Autor:
Haiyan Zeng, Dirk K.M. De Ruysscher, Xiao Hu, Danyang Zheng, Li Yang, Umberto Ricardi, Feng-Ming Spring Kong, Lizza E.L. Hendriks
Publikováno v:
Journal of the National Cancer Center, Vol 2, Iss 2, Pp 113-125 (2022)
Several guidelines including radiotherapy recommendations exist worldwide for the treatment of small cell lung cancer (SCLC). To evaluate the differences in radiotherapy recommendations we conducted a systematic review. PubMed and the sites of medica
Externí odkaz:
https://doaj.org/article/da46e2f5f73c4e8abedd0f07c401bddd
Autor:
Mathijs L. Tomassen, Jacquelien Pomp, Janneke van der Stap, Anne S.R. van Lindert, Max Peters, José S.A. Belderbos, Dirk K.M. De Ruysscher, Steven H. Lin, Joost J.C. Verhoeff, Peter S.N. van Rossum
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 33, Iss , Pp 145-152 (2022)
Background: Prophylactic cranial irradiation (PCI) for limited-stage small-cell lung cancer (LS-SCLC) patients has become more controversial. Since the publication of the systematic review by Aupérin et al. in 1999, no randomized controlled trials r
Externí odkaz:
https://doaj.org/article/6248a69e1fe54b6c8437480ee66ed65a
Autor:
Mathijs L. Tomassen, Mieke J. Aarts, Max Peters, Anne van Lindert, Dirk K.M. De Ruysscher, Joost J.C. Verhoeff, Peter S.N. van Rossum
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 27, Iss , Pp 157-163 (2021)
Introduction: Controversy has arisen regarding the benefit of prophylactic cranial irradiation (PCI) in patients with small cell lung cancer (SCLC), particularly since the 2017 Takahashi trial publication that supports MRI surveillance in extensive-s
Externí odkaz:
https://doaj.org/article/cf2df66925f44ef6949e5ee67a37f31f
Autor:
Chris Burtin, Jacques Bezuidenhout, Karin J.C. Sanders, Anne‐Marie C. Dingemans, Annemie M.W.J. Schols, Stephanie T.H. Peeters, Martijn A. Spruit, Dirk K.M. De Ruysscher
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 11, Iss 2, Pp 424-431 (2020)
Abstract Background Assessment of handgrip strength and fat‐free mass provides quick and objective information on muscle performance and mass that might complement subjective World Health Organization Performance Status (WHO PS). We investigated to
Externí odkaz:
https://doaj.org/article/456677e33c224023b6e14ac3227d0888
Autor:
Chris Burtin, Jacques Bezuidenhout, Karin J.C. Sanders, Anne‐Marie C. Dingemans, Annemie M.W.J. Schols, Stephanie T.H. Peeters, Martijn A. Spruit, Dirk K.M. De Ruysscher
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 12, Iss 2, Pp 526-527 (2021)
Externí odkaz:
https://doaj.org/article/be3bc931b3bf4ac199e97f3f546ae084
Autor:
Willem J.A. Witlox, Bram L.T. Ramaekers, Benjamin Lacas, Cecile Le Pechoux, Alexander Sun, Si-Yu Wang, Chen Hu, Mary Redman, Vincent van der Noort, Ning Li, Matthias Guckenberger, Harm van Tinteren, Lizza E.L. Hendriks, Harry J.M. Groen, Manuela A. Joore, Dirk K.M. De Ruysscher
Publikováno v:
Radiotherapy and Oncology, 170, 95-101. ELSEVIER IRELAND LTD
Radiotherapy and Oncology, 170, 95-101. Elsevier Ireland Ltd
Radiotherapy and Oncology, 170, 95-101. Elsevier Ireland Ltd
INTRODUCTION: In stage III non-small cell lung cancer (NSCLC), prophylactic cranial irradiation (PCI) reduces the brain metastases incidence and prolongs the progression-free survival without improving overall survival. PCI increases the risk of toxi
Autor:
Haiyan Zeng, Lizza E.L. Hendriks, Willem J.A. Witlox, Harry J.M. Groen, Anne-Marie C. Dingemans, John Praag, José Belderbos, Ruud Houben, Vincent van der Noort, Dirk K.M. De Ruysscher
Publikováno v:
Radiotherapy and Oncology, 183:109627. Elsevier Ireland Ltd
Radiotherapy and Oncology, 183:109627. ELSEVIER IRELAND LTD
Radiotherapy and Oncology, 183:109627. ELSEVIER IRELAND LTD
Aim: To identify risk factors for self-reported cognitive impairment in radically treated stage III non-small cell lung cancer (NSCLC). Methods: Cognitive functioning was assessed using the EORTC-QLQ-C30 at seven pre-specified time points in the phas
Autor:
Danielle DF De Haas, Dirk K.M. De Ruysscher, Philippe Lambin, Guido Lammerling, Ludy Lutgens, Madelon Pijls-Johannesma, Jacoba van der Zee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c3cfe04c04631df8ab839fa8ee95d5d
https://doi.org/10.1002/14651858.cd006269
https://doi.org/10.1002/14651858.cd006269
Autor:
De Ruysscher DKM; Dirk K.M. De Ruysscher, MAASTRO Clinic, Maastricht, the Netherlands; and Herbert Decaluwé, University Hospitals Leuven, Leuven, Belgium., Decaluwé H; Dirk K.M. De Ruysscher, MAASTRO Clinic, Maastricht, the Netherlands; and Herbert Decaluwé, University Hospitals Leuven, Leuven, Belgium.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2018 Oct 10; Vol. 36 (29), pp. 2907-2908. Date of Electronic Publication: 2018 Aug 27.